Astra-Sanofi’s RSV therapy 90% effective against infant hospitalizations
NEW YORK ― AstraZeneca and Sanofi's antibody therapy was 90% effective in protecting infants from hospitalizations associated with respiratory syncytial ...
Read moreNEW YORK ― AstraZeneca and Sanofi's antibody therapy was 90% effective in protecting infants from hospitalizations associated with respiratory syncytial ...
Read moreAstraZeneca, the world leader in the production and manufacture of medical drugs and vaccines, announced its participation in the second ...
Read moreEgyptian Minister of Health and Population Khaled Abdel Ghaffar on Monday chaired a forum on pulmonary health. The minister told ...
Read moreNEW YORK - The US health regulator has withdrawn emergency-use authorisation for AstraZeneca's COVID-19 antibody cocktail Evusheld as the treatment ...
Read moreAstraZeneca and health partners launched an initiative to transform outcomes for cancer patients across Africa. Announced on the margins of ...
Read moreLONDON - AstraZeneca on Friday said it now expected sales growth of more than 20 per cent on an increase ...
Read moreAt AstraZeneca, we are pushing the boundaries of science to deliver life-changing medicines – boosting our values of being entrepreneurial ...
Read moreLONDON - AstraZeneca's COVID-19 vaccine still has a role to play in the fight against the pandemic, even as sales ...
Read moreLONDON - British drug maker AstraZeneca Plc said the US Food and Drug Administration approved its cancer drug, jointly developed ...
Read moreAstraZeneca signed a Memorandum of Understanding (MoU) with the Egyptian Authority for Unified Procurement (UPA) last week. Based on the ...
Read moreWould you like to receive notifications on our latest news ?
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.